Regencell Bioscience Holdings Ltd
(RGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 12-2017 | 06-2017 | 12-2016 | |
| Sales | 0 | 0 | 3,163,000 | 0 | 3,197,100 |
| Cost of Goods | N/A | N/A | 1,191,600 | N/A | 1,226,800 |
| Gross Profit | N/A | N/A | 1,971,400 | N/A | 1,970,300 |
| Operating Expenses | 812 | 391 | 1,700,300 | 0 | 1,631,700 |
| Operating Income | -812 | -391 | 271,700 | N/A | 339,400 |
| Interest Expense | 0 | 0 | 125,100 | 0 | 128,100 |
| Other Income | 0 | 0 | 67,300 | 0 | 70,400 |
| Pre-tax Income | -812 | -391 | 213,900 | 0 | 281,700 |
| Income Tax | N/A | N/A | 101,600 | N/A | 111,200 |
| Net Income Continuous | -812 | -391 | 112,300 | N/A | 170,500 |
| Minority Interests | N/A | N/A | 0 | N/A | 100 |
| Net Income | $-812 | $-391 | $112,300 | $N/A | $170,400 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.72 | N/A | 1.09 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.72 | N/A | 1.09 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.72 | N/A | 1.09 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.72 | N/A | 1.09 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | N/A | 1.11 |
| EBITDA(a) | $-803 | $-391 | $526,500 | $N/A | $575,000 |